Cyclopentanone derivatives
    1.
    发明授权
    Cyclopentanone derivatives 失效
    环戊酮衍生物

    公开(公告)号:US3870710A

    公开(公告)日:1975-03-11

    申请号:US33041173

    申请日:1973-02-07

    Applicant: ROUSSEL UCLAF

    Abstract: WHEREIN R is selected from the group consisting of hydrogen and alkyl of 1 to 7 carbon atoms, R1 is selected from the group consisting of hydrogen and carbalkoxy of 1 to 7 alkyl carbon atoms, R2 is selected from the group consisting of hydrogen, carboxy and carbalkoxy of 1 to 7 alkyl carbon atoms, R3 is selected from the group consisting of hydrogen and Alpha tetrahydropyranyl, m is 3,4 or 5 and n is 2,3 or 4 with the proviso that when R1 is carbalkoxy, R is alkyl of 1 to 7 carbon atoms, R2 is hydrogen and R3 is Alpha -tetrahydro pyranyl; when R2 is carbalkoxy, R is alkyl of 1 to 7 carbon atoms, R1 is hydrogen and R3 is Alpha -tetrahydropyranyl and when R2 is carboxy, R and R1 are hydrogen and R3 is Alpha tetrahydropyranyl, which possess the physiological activity of prostaglandins, and salts thereof when R, R1, R2 and R3 are hydrogen, with non-toxic, pharmaceutically acceptable bases and their preparation.

    Novel prostanoic acid derivatives of the formula

    Abstract translation: 式WHEREIN R的新型前列腺烷酸衍生物选自氢和1至7个碳原子的烷基,R 1选自氢和1至7个烷基碳原子的烷氧基,R2选自 由1至7个碳原子的氢,羧基和烷氧基组成的基团,R 3选自氢和α-四氢吡喃基,m为3,4或5,n为2,3或4,条件是当 R1是烷氧基,R是1至7个碳原子的烷基,R2是氢,R3是α-四氢吡喃基; 当R 2为烷氧基时,R为1至7个碳原子的烷基,R 1为氢,R 3为α-四氢吡喃基,当R 2为羧基时,R 1和R 1为氢,R 3为具有前列腺素生理活性的α-四氢吡喃基, 当R,R 1,R 2和R 3为氢时,其盐为无毒,药学上可接受的碱及其制备。

    Synthesis of pyrethric acid
    2.
    发明授权
    Synthesis of pyrethric acid 失效
    合成酸

    公开(公告)号:US3694472A

    公开(公告)日:1972-09-26

    申请号:US3694472D

    申请日:1970-05-12

    Applicant: ROUSSEL UCLAF

    CPC classification number: C07C62/16

    Abstract: BY REACTING 3,3-DIMETHYL-2-FORMYL-1-CYCLOPROPANECARBOXYLIC (1R, 2R) acid or a salt thereof with methyl propionate under anhydrous basic conditions.

    A novel process for the preparation of 3,3-dimethyl-2-(2''methoxycarbonyl-trans 1''-propenyl)-1-cyclopropane carboxylic (1R, 2R) acid or d-trans pyrethric (1R,2R) acid of the formula

    Abstract translation: 制备3,3-二甲基-2-(2'-甲氧基羰基 - 反式-1'-丙烯基)-1-环丙烷羧酸(1R,2R)酸或d-反式除虫菊酸(1R,2R)酸的新方法 通过在无水碱性条件下将3,3-二甲基-2-甲基-1-环丙基碳酰氧基(1R,2R)酸或其盐与丙酸甲酯反应。

    Derivatives of 9h-pyrido(3,4-b) indole and process of preparation
    4.
    发明授权
    Derivatives of 9h-pyrido(3,4-b) indole and process of preparation 失效
    9H-吡啶(3,4-B)吲哚的衍生物及其制备方法

    公开(公告)号:US3862160A

    公开(公告)日:1975-01-21

    申请号:US38206173

    申请日:1973-07-24

    Applicant: ROUSSEL UCLAF

    Abstract: The preparation of derivatives of 1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole is described. In particular the preparation of acrylic esters of Beta -(3''-hydroxypropyl)-1,2,3,4-tetrahydro9H-pyrido (3,4-b) indole is shown to proceed from the oxidation of a 2-alkyloxy-3-hydroxytetrahydropyran to its 2-alkyloxy-3oxotetrahydropyran derivative. The Wittig condensation is used to effect the reaction of this ketone with a phosphonoacetic ester giving rise to the carbalkoxy methylenic-substitution product, 2alkyloxy-3-(1''-alkoxycarbonyl)methylidenetetrahydropyran. After acid hydrolysis of the 2-alkyloxy group, condensation is carried out with tryptamine resulting in the desired indole derivatives. Such compounds can be used in the facile preparation of alkaloids of the eburnamonie family.

    Abstract translation: 描述了1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚衍生物的制备。 具体地说,β-(3'-羟丙基)-1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚的丙烯酸酯的制备显示出从2-烷氧基 -3-羟基四氢吡喃与其2-烷氧基-3-氧代四氢吡喃衍生物。 维t嗪缩合用于使该酮与一种膦酰基乙酸酯反应,生成2-烷氧基-3-(1'-烷氧基羰基)亚甲基四氢吡喃的烷氧基亚甲基取代产物。 在2-烷氧基酸水解后,用色胺进行缩合,产生所需的吲哚衍生物。 这些化合物可用于易燃鳗ie族家族生物碱的制备。

Patent Agency Ranking